Top Markets
Coin of the day
NeuroSense Therapeutics Ltd. NeuroSense Therapeutics Ltd.

NeuroSense Therapeutics Ltd.

NRSN
Ранг среди акций #31074
NeuroSense Therapeutics Ltd. operates as a biotechnology firm in the clinical... NeuroSense Therapeutics Ltd. operates as a biotechnology firm in the clinical development phase, committed to discovering and developing effective therapies for individuals suffering from severe neurodegenerative conditions. The company's leading drug candidate, PrimeC, is an innovative oral formulation that has successfully concluded Phase IIa clinical investigations for the management of amyotrophic lateral sclerosis (ALS). Additionally, its early-stage research pipeline features StabiliC, a potential treatment for Parkinson's disease, and CogniC, which is under development for Alzheimer's disease. Established in 2017, NeuroSense Therapeutics Ltd. is headquartered in Herzliya, Israel.
Цена акции
$0.404
Рыночная капитализация
$14.28M
Изменение (1 день)
-10.42%
Изменение (1 год)
-67.68%
Страна
IL
Торговля NeuroSense Therapeutics Ltd. (NRSN)

Категория

История цены акций NeuroSense Therapeutics Ltd. (NRSN)
Наивысшая цена закрытия: $0.47 2026-08-01

Наименьшая цена закрытия: $3.04 2021-12-01
История цены акций NeuroSense Therapeutics Ltd. с 2021 по 2026
Годовая динамика цены акций
Год Результативность
2026 (TTM) -1.04%
2025 -17.69%
2024 31.68%
2023 -42.23%
2022 -51.82%
2021 0.00%
Цена акций похожих компаний или конкурентов
Компания Цена акций Изменение 1г% Страна
$528.88 35.65%
US
$1.00K 51.38%
NL
$111.31 -36.83%
AU
$735.86 6.87%
CH
$257.75 13.01%
BE